Defining safety parameters for first-trimester malaria treatment trials: stakeholder views from Real-Time Delphi survey
An international real-time Delphi study conducted with Surveylet (Calibrum Inc., Utah, USA) involved 30 stakeholders, including researchers, clinicians, policymakers, and regulators, to identify important maternal and infant safety endpoints and acceptable non-inferiority margins for first-trimester antimalarial treatment trials. The published methods explicitly identify the Surveylet platform.

